Proteoglycans synthesized by arterial smooth muscle cells in the presence of transforming growth factor-β1 exhibit increased binding to LDLs

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 22, Issue 1, 2002, Pages 55-60

  Little, Peter J ^a   Tannock, Lisa ^a   Olin, Katherine L ^a   Chait, Alan ^a   Wight, Thomas N ^a  

^a HOPE HEART INSTITUTE   (United States)

Author keywords

Glycosaminoglycans; Lipoproteins; Proteoglycans; Smooth muscle cells; Transforming growth factor 1

Indexed keywords

GLYCOSAMINOGLYCAN; LOW DENSITY LIPOPROTEIN; METHYL BETA XYLOPYRANOSIDE; PROTEOGLYCAN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; XYLOSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY MUSCLE; ARTICLE; ATHEROGENESIS; BINDING AFFINITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; LIPID STORAGE; MONKEY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN ISOLATION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; PROTEOGLYCAN SYNTHESIS; REGULATORY MECHANISM;

GLYCOSAMINOGLYCANS; GLYCOSIDES; HUMANS; LIPOPROTEINS, LDL; MUSCLE, SMOOTH, VASCULAR; PROTEOGLYCANS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0036143394     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/hq0102.101100     Document Type: Article

References (36)

1. Insulin sensitivity in subjects with type 2 diabetes: Relationship to cardiovascular risk factors: The insulin resistance atherosclerosis study
2. Shattuck lecture: Cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities
3. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality
4. Arterial wall proteoglycans: Biological properties related to pathogenesis of atherosclerosis
5. The response to retention hypothesis of early atherogenesis
6. Cellular consequences of the association of apoB lipoproteins with proteoglycans: Potential contribution to atherogenesis
7. Association of apo B lipoproteins with arterial proteoglycans: Pathological significance and molecular basis
8. Interaction of native and modified low-density lipoproteins with extracellular matrix
9. Production of transforming growth factor beta 1 during repair of arterial injury
10. Direct gene transfer of transforming growth factor β1 gene into arteries stimulates fibrocellular hyperplasia
11. Transforming growth factor-beta 1 gene activation and growth of smooth muscle from hypertensive rats
12. Distinct patterns of transforming growth factor-beta isoform and receptor expression in human atherosclerotic lesions: Colocalization implicates TGF-beta in fibrofatty lesion development
13. Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor-beta
14. TGF-betas and TGF-beta receptors in atherosclerosis
15. Cultured porcine coronary artery smooth muscle cells: A new model with advanced differentiation
16. Subendothelial proteoglycan synthesis and transforming growth factor beta distribution correlate with susceptibility to atherosclerosis
17. Effects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells
18. Platelet-derived growth factor and transforming growth factor-beta 1 differentially affect the synthesis of biglycan and decorin by monkey arterial smooth muscle cells
19. Prominence of apolipoproteins B, (a) and E in the intimae of coronary arteries in transplanted human hearts: Geographic relationship to vessel wall proteoglycans
20. Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: Colocalization of biglycan with apolipoproteins
21. Differences in the distribution of versican, decorin, and biglycan in atherosclerotic human coronary arteries
22. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localized to areas of versican deposits
23. Regional differences in the distribution of the proteoglycans, biglycan, and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries
24. Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells
25. Altered proteoglycan synthesis via the false acceptor pathway can be dissociated from beta-D-xyloside inhibition of proliferation
26. A novel assay for the biosynthesis of sulfated polysaccharide and its application to studies on the effects of somatomedin on cultured cells
27. Proteoglycans: Isolation and purification from tissue cultures
28. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
29. A method for the determination of the molecular weight and molecular-weight distribution of chondroitin sulfate
30. Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells
31. Measurements of proteoglycan-lipoprotein interaction by gel mobility shift assay
32. Glycosaminoglycan fractions from human arteries presenting diverse susceptibilities to atherosclerosis have different binding affinities to plasma LDL
33. Oxidized low density lipoproteins regulate synthesis of monkey aortic smooth muscle cell proteoglycans that have enhanced native low density lipoprotein binding properties
34. Binding of low density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells
35. Injury to the arterial wall of rabbits produces proteoglycan variants with enhanced low-density lipoprotein-binding property
36. Transforming growth factor-beta induces selective increase of proteoglycan production and changes in the copolymeric structure of dermatan sulphate in human skin fibroblasts